Benefits of using PRP Therapy in Various Gynecological Diseases

Najmutdinova D.  K.; Kamilova I.  A.; Gadoyeva D.  A.

Najmutdinova D. K. DSc in medical sciences, professor of department “Obstetrics and gynecology in family medicine” of Tashkent medical academy
Kamilova I. A. DSc in medical sciences, Assistant of department “Obstetrics and gynecology in family medicine” of Tashkent medical academy
Gadoyeva D. A. Assistant of department “Obstetrics and gynecology in family medicine” of Tashkent medical academy

Keywords: growth factors, gynecologic diseases, inflammation, ovarian reserve, regeneration, PRP- therapy

Abstract

Platelet rich plasma is autologous blood, containing high levels of growth and anti-inflammatory factors. This method is widely used and proven in various fields of modern medicine, including plastic surgery, sports medicine, tendon and ligament injuries, traumatology, dermatology, and gynecological diseases. A healthy organism has the ability to overcome small injuries independently, because the regeneration process is actively carried out under physiological conditions. When there is contact with pathogenic organisms, in cases of blood circulation disorders, hormonal changes, due to deficiencies in the immune system, the recovery process slows down and loses its activity. In such cases, using the platelet rich plasma (PRP) accelerates the recovery process due to its high anti-inflammatory effectiveness and growth factors.

References

Lauren H. Redler, Scott A. Thompson “Platelet-Rich Plasma Therapy: A Systematic Literature Review and Evidence for Clinical Use” The Physician and Sportsmedicine. Volume 39, 2011;

Adrian D.K. Le, Lawrence Enweze, Malcolm R. DeBraun “Plateled-rich plasma” Clinics in Sports Medicine. Volume 38, 2019;

Shyla Gupta, Anna Paliczak “Evidence-based indications of platelet-rich plasma therapy” Expert rewiev of hematology, volume 14, 2021;

Voja Pavlovic, Nilab Ciric, Vladimir Jovanovic“Platelet Rich Plasma: a short overview of certain bioactive components”. Open medicine, volume 11, 2016;

Yogita Dagda, Neeta Signh “Autologous platelet-rich plasma optimizes endometrial thickness and pregnancy outcomes in women with refractory thin endometrium of varied aetiology during fresh and frozen-thawed embryo transfer cycles” JBRA Assisted Reproduction 2022;

Kelton Tremellen, Leanne Pacella-Ince “An audit of clinical outcomes following ovarian administration of platelet-rich plasma (PRP) in women with severe diminished ovarian reserve”. Australian and New Zealand Journal of Obstetrics and Gynaecology Volume 62, 2022;

Yigit Cakiroglu, Ayse Saltik, Aysen Yeceturk “Effects of intraovarian injection of autologous platelet rich plasma on ovarian reserve and IVF outcome parameters in women with primary ovarian insufficiency. AgING, volume 12, 2020”

Anastasia Prodromidou, Dimitrios Zacharakis “The Emerging Role on the Use of Platelet-Rich Plasma Products in the Management of Urogynaecological Disorders”. Surgical Innovation, volume 29, 2022.